• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高头颈部癌症肿瘤分期的价值:代谢参数作为预后因素的作用。

Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Puerta de Hierro University Hospital, Madrid, Spain.

Autonomous University of Madrid, Madrid, Spain.

出版信息

Head Neck. 2021 Aug;43(8):2477-2487. doi: 10.1002/hed.26725. Epub 2021 May 6.

DOI:10.1002/hed.26725
PMID:33955080
Abstract

BACKGROUND

Validated biomarkers in head and neck squamous cell carcinoma (HNSCC) are scarce.

METHODS

We retrospectively analyzed 62 patients with HNSCC treated with radiotherapy +/- concurrent chemotherapy. Pretreatment metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured in a F-FDG positron emission tomography using a liver dependent standardized uptake value threshold. Cox regression analyses were performed to find associations with disease-free survival (DFS) and overall survival (OS).

RESULTS

High values of MTV (>37 ml) were independently associated with a worse DFS (hazard ratio [HR] = 3.45; 95% confidence interval [CI], 1.52-7.84) and OS (HR = 3.27; 95% CI, 1.41-7.57). Similar results were found for high values of TLG (>247 g) for DFS (HR = 3.32; 95% CI, 1.44-7.65) and OS (HR = 3.42; 95% CI, 1.45-8.07).

CONCLUSIONS

MTV and TLG can be considered as independent prognostic factors for DFS and OS in patients with HNSCC. Considering how easily obtainable they are, they may be useful for predicting clinical outcomes in these patients.

摘要

背景

头颈部鳞状细胞癌(HNSCC)中有效的生物标志物稀缺。

方法

我们回顾性分析了 62 例接受放疗 +/- 同期化疗的 HNSCC 患者。使用基于肝脏的标准化摄取值阈值,在 F-FDG 正电子发射断层扫描中测量治疗前代谢肿瘤体积(MTV)和总病变糖酵解(TLG)。Cox 回归分析用于寻找与无病生存(DFS)和总生存(OS)相关的因素。

结果

高 MTV 值(>37ml)与较差的 DFS(风险比[HR] = 3.45;95%置信区间[CI],1.52-7.84)和 OS(HR = 3.27;95% CI,1.41-7.57)独立相关。TLG 高值(>247g)也与 DFS(HR = 3.32;95% CI,1.44-7.65)和 OS(HR = 3.42;95% CI,1.45-8.07)相关。

结论

MTV 和 TLG 可作为 HNSCC 患者 DFS 和 OS 的独立预后因素。考虑到它们很容易获得,它们可能有助于预测这些患者的临床结局。

相似文献

1
Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.提高头颈部癌症肿瘤分期的价值:代谢参数作为预后因素的作用。
Head Neck. 2021 Aug;43(8):2477-2487. doi: 10.1002/hed.26725. Epub 2021 May 6.
2
Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.代谢肿瘤体积和总病变糖酵解作为头颈癌的预后因素:系统评价和荟萃分析
Head Neck. 2020 Dec;42(12):3744-3754. doi: 10.1002/hed.26461. Epub 2020 Sep 11.
3
Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.18F-FDG PET 中 MTV 和 TLG 对头颈部鳞状细胞癌患者的预后价值:一项荟萃分析。
Medicine (Baltimore). 2022 Sep 30;101(39):e30798. doi: 10.1097/MD.0000000000030798.
4
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
5
Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.下咽鳞状细胞癌治疗前代谢肿瘤体积和总病变糖酵解的临床意义
J Surg Oncol. 2014 Dec;110(7):869-75. doi: 10.1002/jso.23729. Epub 2014 Aug 2.
6
Use of F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck.F-FDG PET/CT成像在诱导化疗后对头颈部局部晚期鳞状细胞癌放疗靶区勾画及预后评估中的应用。
Medicina (Kaunas). 2018 Dec 10;54(6):107. doi: 10.3390/medicina54060107.
7
Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.评估 FDG PET/CT 参数对手术治疗头颈部癌症患者预后的价值:系统评价。
JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):471-479. doi: 10.1001/jamaoto.2020.0014.
8
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.国际多中心鼻咽癌队列研究中基线 [18F]-氟脱氧葡萄糖正电子发射断层扫描参数 MTV、TLG 和非球形度的预后价值。
PLoS One. 2020 Jul 30;15(7):e0236841. doi: 10.1371/journal.pone.0236841. eCollection 2020.
9
Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.代谢肿瘤体积和总病变糖酵解在晚期宫颈癌患者中的预后意义
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):17-21. doi: 10.1016/j.remn.2018.08.001. Epub 2018 Oct 23.
10
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者治疗前 18F-FDG PET/CT 参数(包括视觉评估)的预后价值。
AJR Am J Roentgenol. 2014 Apr;202(4):851-8. doi: 10.2214/AJR.13.11013.

引用本文的文献

1
Determination of diagnostic and predictive parameters for vertical mandibular invasion in patients with lower gingival squamous cell carcinoma: A retrospective study.确定下颌牙龈鳞癌患者垂直下颌骨侵犯的诊断和预测参数:一项回顾性研究。
Medicine (Baltimore). 2022 Dec 9;101(49):e32206. doi: 10.1097/MD.0000000000032206.
2
Utility and limitations of metabolic parameters in head and neck cancer: finding a practical segmentation method.代谢参数在头颈部肿瘤中的应用及局限性:寻找一种实用的分割方法。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4577-4586. doi: 10.1007/s00405-022-07401-y. Epub 2022 May 2.
3
Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with F-FDG PET/CT: A Single-Center Prospective Study.
尿激酶型纤溶酶原激活物受体 PET/CT 对头颈部鳞状细胞癌的预后价值及与 F-FDG PET/CT 的比较:一项单中心前瞻性研究。
J Nucl Med. 2022 Aug;63(8):1169-1176. doi: 10.2967/jnumed.121.262866. Epub 2021 Dec 2.